Pacific Beach BioSciences and Dong Wha Pharmaceuticals Sign Exclusive License Agreement to Develop and Commercialize Zabofloxacin (PB-101, DW-224a)
August 10, 2007 07:00 ET
|
Pacific Beach BioSciences, Inc.
SAN DIEGO, Aug. 10, 2007 (PRIME NEWSWIRE) -- Pacific Beach BioSciences, Inc. (PB BioSciences), a development stage biopharmaceutical company that develops novel therapeutics for the treatment and...